Prospective Study of an Investigational Daily Disposable Contact Lens
NCT ID: NCT01295905
Last Updated: 2012-07-10
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2011-01-31
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
delefilcon A
Investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for 3 months.
delefilcon A contact lens
Investigational silicone hydrogel, single vision soft contact lens
narafilcon B
Commercially marketed contact lenses worn in both eyes on a daily wear, daily disposable basis for 3 months.
narafilcon B contact lens
Commercially marketed silicone hydrogel, single vision soft contact lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
delefilcon A contact lens
Investigational silicone hydrogel, single vision soft contact lens
narafilcon B contact lens
Commercially marketed silicone hydrogel, single vision soft contact lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be of legal age of consent and sign Informed Consent document. If under legal age of consent, legally authorized representative must sign Informed Consent document and subject must sign Assent document.
* Willing and able to wear spherical contact lenses for at least 5 days per week.
* Willing and able to wear spherical contact lenses within the available range of powers of -1.00 diopter(D) to -6.00D in 0.25D steps.
* Best spectacle-corrected visual acuity greater than or equal to 20/25.
* Manifest cylinder less than or equal to 0.75D.
Exclusion Criteria
* Any use of systemic medications for which contact lens wear could be contraindicated as determined by the investigator.
* History of refractive surgery or irregular cornea.
* History of pathologically dry eye.
* Eye injury within twelve weeks immediately prior to enrollment for this trial.
* Currently enrolled in any clinical trial.
* Participation in a contact lens or contact lens care product clinical trial within the previous 30 days.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CIBA VISION
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P-347-C-004
Identifier Type: -
Identifier Source: org_study_id